ID

19746

Description

A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025); ODM derived from: https://clinicaltrials.gov/show/NCT00251589

Link

https://clinicaltrials.gov/show/NCT00251589

Keywords

Versions (1)
  1. 1/25/17 1/25/17 -
Uploaded on

January 25, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non-Small-Cell Lung NCT00251589

English

Eligibility Carcinoma, Non-Small-Cell Lung NCT00251589

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females 18 years of age and older with a confirmed diagnosis of non-small-cell lung cancer (nsclc) who have failed at least one prior treatment for nsclc.
Description

Age | Non-Small Cell Lung Carcinoma | Therapeutic procedure Quantity failed

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007131
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0231175
patients must have proven disease by ct scan or mri.
Description

Disease Proven X-Ray Computed Tomography | Magnetic Resonance Imaging

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0456369
UMLS CUI [1,3]
C0040405
UMLS CUI [2]
C0024485
patients must be at least 4 weeks from any chemotherapy for cancer or from any surgeries or from any treatment using an investigational drug.
Description

Chemotherapy Malignant Neoplasms Status post | Operative Surgical Procedures Status post | Investigational New Drugs Status post

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
UMLS CUI [1,3]
C0231290
UMLS CUI [1,4]
C0231290
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C0231290
UMLS CUI [3,1]
C0013230
UMLS CUI [3,2]
C0231290
patients must be 2 weeks out from radiation therapy.
Description

Therapeutic radiology procedure Status post

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0231290
at screening the patient must have normal lab results and can not be pregnant.
Description

Normal Laboratory Test Result | Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0438214
UMLS CUI [2]
C0032961
women and men must agree to practice adequate birth control during the study.
Description

Gender Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
patient has the ability to understand and sign the consent form.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient had prior treatment with vorinostat or erlotinib.
Description

Vorinostat | erlotinib

Data type

boolean

Alias
UMLS CUI [1]
C0672708
UMLS CUI [2]
C1135135
patient has any of the following conditions: active infections including hepatitis b or c, unstable brain metastases, swallowing difficulties, heart problems, significant eye abnormalities, drug or alcohol abuse, mental illness or pregnancy.
Description

Communicable Diseases | Hepatitis B | Hepatitis C | Metastatic malignant neoplasm to brain Unstable | Deglutition Disorders | HEART PROBLEM | Eye Abnormalities Significant | Substance Use Disorders | Mental disorders | Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
UMLS CUI [4,1]
C0220650
UMLS CUI [4,2]
C0443343
UMLS CUI [5]
C0011168
UMLS CUI [6]
C0795691
UMLS CUI [7,1]
C0015393
UMLS CUI [7,2]
C0750502
UMLS CUI [8]
C0038586
UMLS CUI [9]
C0004936
UMLS CUI [10]
C0032961
Back to the top of the page

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT00251589

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma | Therapeutic procedure Quantity failed
Item
males and females 18 years of age and older with a confirmed diagnosis of non-small-cell lung cancer (nsclc) who have failed at least one prior treatment for nsclc.
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0231175 (UMLS CUI [3,3])
Disease Proven X-Ray Computed Tomography | Magnetic Resonance Imaging
Item
patients must have proven disease by ct scan or mri.
boolean
C0012634 (UMLS CUI [1,1])
C0456369 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C0024485 (UMLS CUI [2])
Chemotherapy Malignant Neoplasms Status post | Operative Surgical Procedures Status post | Investigational New Drugs Status post
Item
patients must be at least 4 weeks from any chemotherapy for cancer or from any surgeries or from any treatment using an investigational drug.
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0231290 (UMLS CUI [1,3])
C0231290 (UMLS CUI [1,4])
C0543467 (UMLS CUI [2,1])
C0231290 (UMLS CUI [2,2])
C0013230 (UMLS CUI [3,1])
C0231290 (UMLS CUI [3,2])
Therapeutic radiology procedure Status post
Item
patients must be 2 weeks out from radiation therapy.
boolean
C1522449 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Normal Laboratory Test Result | Pregnancy
Item
at screening the patient must have normal lab results and can not be pregnant.
boolean
C0438214 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Gender Contraceptive methods
Item
women and men must agree to practice adequate birth control during the study.
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
patient has the ability to understand and sign the consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Vorinostat | erlotinib
Item
patient had prior treatment with vorinostat or erlotinib.
boolean
C0672708 (UMLS CUI [1])
C1135135 (UMLS CUI [2])
Communicable Diseases | Hepatitis B | Hepatitis C | Metastatic malignant neoplasm to brain Unstable | Deglutition Disorders | HEART PROBLEM | Eye Abnormalities Significant | Substance Use Disorders | Mental disorders | Pregnancy
Item
patient has any of the following conditions: active infections including hepatitis b or c, unstable brain metastases, swallowing difficulties, heart problems, significant eye abnormalities, drug or alcohol abuse, mental illness or pregnancy.
boolean
C0009450 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0220650 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0011168 (UMLS CUI [5])
C0795691 (UMLS CUI [6])
C0015393 (UMLS CUI [7,1])
C0750502 (UMLS CUI [7,2])
C0038586 (UMLS CUI [8])
C0004936 (UMLS CUI [9])
C0032961 (UMLS CUI [10])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial